Embiosys Inc.

North Andover, MA Embiosys Inc.

UEI
Q9PEK2FTD4H6
CAGE
9FEH5
Primary NAICS
339112 Surgical and Medical Instrument Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
489 Sharpners Pond Rd, North Andover, MA 01845, USA
Website
embiosys.com
Founded
2022
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Embiosys Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Current: capecitabine in RCB2/3 with a wearable induced electric field device in triple negative breast cancer - project… Grant · R44CA310518 National Cancer Institute $2,758,884
Development of a wearable, non-invasive, treatment device for metastatic triple-negative breast cancer (tnbc) -… Grant · R43CA287836 National Cancer Institute $611,125

Quick answers

What is Embiosys Inc.'s UEI?

Embiosys Inc.'s Unique Entity ID (UEI) in SAM.gov is Q9PEK2FTD4H6.

What is Embiosys Inc.'s CAGE code?

Embiosys Inc.'s CAGE code is 9FEH5.

What is Embiosys Inc.'s primary NAICS code?

Embiosys Inc.'s primary NAICS code is 339112 (Surgical and Medical Instrument Manufacturing).

Where is Embiosys Inc. located?

Embiosys Inc.'s physical address in SAM.gov is 489 Sharpners Pond Rd, North Andover, MA 01845, USA.

Is Embiosys Inc. registered in SAM.gov?

Yes. Embiosys Inc.'s SAM.gov registration is active through June 19, 2027.

What is Embiosys Inc.'s most recent federal award?

Embiosys Inc.'s most recent federal grant award is Current: capecitabine in RCB2/3 with a wearable induced electric field device in triple negative breast cancer - project… (R44CA310518), from National Cancer Institute, on September 17, 2025.

On GovTribe

See Embiosys Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login